During the past decade, National Cancer Institute conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Cancer Institute" #1 sponsor was "Universiti Putra Malaysia" with 4 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Kura Oncology, Inc." with 1 trials sponsored and "National Cancer Center, Japan" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Cancer Institute" #1 collaborator was "National Cancer Institute, Malaysia" with 3 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "National Cancer Institute" are "Carcinoma, Non-Small-Cell Lung" (1 trials), "Cervical Cancer" (1 trials), "Endometrial Cancer" (1 trials), "Fast Track Recovery Surgery" (1 trials) and "HNSCC" (1 trials). Many other conditions were trialed in "National Cancer Institute" in a lesser frequency.

Most popular intervention types in "National Cancer Institute" are "Drug" (6 trials), "Device" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Abemaciclib" (1 trials), "Carboplatin" (1 trials), "Dinutuximab" (1 trials) and "EU-approved Avastin®" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Cancer Institute" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "National Cancer Institute". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in National Cancer Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Cancer Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".